Details for New Drug Application (NDA): 214313
✉ Email this page to a colleague
The generic ingredient in NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE is norepinephrine bitartrate. There are five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
Summary for 214313
Tradename: | NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE |
Applicant: | Baxter Hlthcare Corp |
Ingredient: | norepinephrine bitartrate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 214313
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 214313 | NDA | Baxter Healthcare Corporation | 0338-0108 | 0338-0108-20 | 20 CONTAINER in 1 CARTON (0338-0108-20) / 250 mL in 1 CONTAINER |
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 214313 | NDA | Baxter Healthcare Corporation | 0338-0112 | 0338-0112-20 | 20 BAG in 1 CARTON (0338-0112-20) / 250 mL in 1 BAG |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) | ||||
Approval Date: | Jan 15, 2021 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | ||||
Approval Date: | Jan 15, 2021 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | ||||
Approval Date: | Nov 21, 2023 | TE: | RLD: | Yes |
Complete Access Available with Subscription